Which entity is responsible for negotiating and enforcing Corporate Integrity Agreements (CIA)?

The Office of Inspector General (OIG) is the entity tasked with negotiating and enforcing Corporate Integrity Agreements (CIA). These agreements are vital tools used by the OIG to promote compliance and prevent fraud within healthcare organizations that have previously engaged in questionable conduct.

The OIG develops CIAs as part of settlements involving civil or administrative violations, ensuring that the organization implements specific compliance measures and adheres to regulations designed to prevent future misconduct. The OIG monitors compliance with the terms of these agreements, which can include requirements for establishing compliance programs, reporting violations, and making educational resources available to staff.

The other entities mentioned—CDC, NIH, and FDA—do not play a role in CIAs. The CDC focuses on public health and disease prevention, the NIH is dedicated to biomedical research, and the FDA is responsible for regulating food, drugs, and medical devices. Each has a distinct area of focus that does not involve enforcing compliance agreements related to corporate integrity.